Alzamend Neuro logo
Alzamend Neuro
ALZN | NASDAQ
Chart Builder DCF Calculator
$1.18
-$0.06 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$1.16
-$0.02 (-1.69%)
After-hours: Nov 16, 2026, 6:04 PM ET

Alzamend Neuro Company Profile

Company profile explained

Company Profile

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Key Executives

Name Position
Stephan Jackman Chief Executive Officer & Director
David J. Katzoff Chief Financial Officer
Henry C. W. Nisser Executive Vice President, General Counsel & Director
Kenneth S. Cragun Senior Vice President of Finance
Milton Charles Ault Founder & Vice Chairman

Latest SEC Filings

Date Type Title
Oct 09, 2026 RW Filing
Sep 29, 2026 8-K Current Report
Sep 10, 2026 10-Q Quarterly Report
Aug 31, 2026 4 Filing
Aug 31, 2026 4/A [Amend] Filing
Aug 31, 2026 4/A [Amend] Filing
Aug 28, 2026 PRE 14A Filing
Aug 21, 2026 S-1 Filing
Aug 20, 2026 4/A [Amend] Filing
Aug 20, 2026 3/A [Amend] Filing
View All SEC Filings ➞
Alzamend Neuro
Alzamend Neuro logo
Country United States
IPO Date Jun 15, 2021
Industry Biotechnology
Sector Healthcare
Employees 6
CEO Stephan Jackman

Contact Details

3480 Peachtree Road NE Atlanta, Georgia 30326 United States

Stock Details

Ticker Symbol ALZN
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001677077
CUSIP Number 02262M605
ISIN Number US02262M6057
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.